BlackRock Health Sciences Trust II (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Trust II (NYSE:BMEZGet Rating) was the recipient of a significant growth in short interest during the month of December. As of December 30th, there was short interest totalling 25,900 shares, a growth of 56.0% from the December 15th total of 16,600 shares. Based on an average daily trading volume, of 534,500 shares, the days-to-cover ratio is currently 0.0 days.

BlackRock Health Sciences Trust II Price Performance

BMEZ opened at 16.51 on Friday. The company’s 50-day moving average is 15.82 and its 200 day moving average is 16.02. BlackRock Health Sciences Trust II has a fifty-two week low of 14.33 and a fifty-two week high of 22.49.

BlackRock Health Sciences Trust II Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, January 31st. Shareholders of record on Friday, January 13th will be given a $0.145 dividend. This represents a $1.74 annualized dividend and a yield of 10.54%. The ex-dividend date is Thursday, January 12th.

Institutional Trading of BlackRock Health Sciences Trust II

Several hedge funds have recently added to or reduced their stakes in BMEZ. Nelson Van Denburg & Campbell Wealth Management Group LLC bought a new stake in shares of BlackRock Health Sciences Trust II in the third quarter valued at approximately $29,000. MUFG Americas Holdings Corp purchased a new position in BlackRock Health Sciences Trust II during the third quarter valued at approximately $30,000. Arlington Partners LLC purchased a new position in BlackRock Health Sciences Trust II during the fourth quarter valued at approximately $46,000. Blue Bell Private Wealth Management LLC grew its stake in BlackRock Health Sciences Trust II by 62.9% in the 2nd quarter. Blue Bell Private Wealth Management LLC now owns 7,422 shares of the company’s stock worth $122,000 after buying an additional 2,867 shares in the last quarter. Finally, Dowling & Yahnke LLC purchased a new position in BlackRock Health Sciences Trust II in the 3rd quarter worth approximately $149,000.

About BlackRock Health Sciences Trust II

(Get Rating)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Featured Stories

Receive News & Ratings for BlackRock Health Sciences Trust II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust II and related companies with MarketBeat.com's FREE daily email newsletter.